coronavirus vaccine, U.S. drugmaker Moderna said its candidate has proven to be nearly 95 per cent effective in protecting people from the COVID-19 disease, according to preliminary results.Monday’s announcement was based on interim data from its ongoing late-stage trial, raising hopes in the fight against the pandemic that has so far killed more than 1.32 million people worldwide.“94.5 per cent efficacy and preventing COVID-19 is frankly well above the minimum thresholds that most of us had set for trying to stop a pandemic,” Moderna president Stephen Hoge told Global News on Monday.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.